Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-023330

Chief Legal Officer sold 1,909 shares at $30.00 ($57,270)

  • Chief Legal Officer acquired 1,909 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2024-02-27 Option exercise 10b5-1 +1,909 $20.24 $38,638 3,646 D: show line 1 in the form
Bizily Scott Chief Legal Officer 2024-02-27 Sale 10b5-1 −1,909 $30.00 $57,270 1,737 D: show line 2 in the form
Open-market sales · 1,909 sh · avg $30.00 · $57,270

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bizily Scott Chief Legal Officer 2024-02-27 Option exercise · Stock Option (Right To Buy) 10b5-1 −1,909 48,091 D: show line 3 in the form
Loading xslF345X05/ownership.xml…